Invitation: Elekta’s Interim Report for May-July 2011/12
Elekta’s interim report for the first three months 2011/12 will be published on September 13, 2011 with the following schedule:
- The report will be published on September 13, at around 13.00 CET.
- Elekta will host a telephone conference 18.00-18.45 CET on September 13, with CEO Tomas Puusepp and CFO Håkan Bergström. Since the AGM is held the same day there will be limited time for the conference call.
To take part in the conference call, please dial in about 5-10 minutes in advance.
- Swedish dial-in number: +46 (0)8 5052 0110
- UK dial-in number: +44 (0)20 7162 0077
- US dial-in number: + 1 334 323 6201
The telephone conference will also be broadcasted over the Internet (audio only). Please use the link http://webeventservices.stream57.com/20110913elekta
A replay of the telephone conference will be available until September 27, 2011. Please dial Sweden: +46 (0)8 5052 0333, UK: +44 (0)20 7031 4064, US: +1 954 334 0342, and use access code 902264. The conference replay will as well be available on the link above.
For further information, please contact:
Johan Andersson Melbi, Investor Relations Manager, Elekta AB.
+46 702 100 451, email@example.com.
The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 16.00 CET on September 1, 2011.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today.
Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.
Elekta employs around 2,800 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker Elekta. Website: www.elekta.com